Our business

Overview

Emcure Pharmaceuticals has established itself as a reputed and diversified biopharmaceutical company in the past three decades

With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world. With a strong focus on research and development, the company offers a wide range of products and services under formulations, biologics, APIs and is currently Emcure’s subsidiary – Gennova working on the mRNA platform, including a vaccine for COVID19.

Know More About Our Offerings

Quick Explore

Left Nav
Right Nav